The Triple Negative Breast Cancer market was valued at USD 1.06 Billion in 2024 and is expected to reach USD 1.63 Billion by 2032, growing at a CAGR of 5.5% (2025-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.